The Estonian Biobank has chosen PacBio for whole genome sequencing, aiming to sequence the genomes of 10,000 participants. This advanced technology will allow for in-depth analysis of genetic data, leading to new insights in health policy and strategy. The Institute of Genomics at the University of Tartu will utilize the Revio HiFi sequencing system to unlock diverse data and analyze complex variations, including the epigenome. The project aims to improve understanding of genetics in areas such as cardiovascular disease, cancer, and treatment outcomes, with potential for personalized medicine at scale. This initiative marks a significant step towards realizing health benefits for the Estonian population and beyond.